Login / Signup

Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations.

Ola CasterYasunori AokiLucie M GattepailleBirgitta Grundmark
Published in: Drug safety (2021)
To mitigate the risk of highlighting spurious associations with disproportionality analysis, a minimum size of 500 reports is recommended for national databases. For databases or subsets that are not country-specific, our recommendation is 5000 reports. This study does not consider sensitivity, which is expected to be poor in smaller databases.
Keyphrases
  • big data
  • adverse drug
  • emergency department
  • machine learning
  • clinical practice
  • deep learning
  • drug induced
  • loop mediated isothermal amplification
  • electronic health record
  • real time pcr